Biotech and Pharma
Case Study No. 3 in How to Make Nuclear Innovative
What will it take to bring 21st-century innovation to the nuclear industry? How to Make Nuclear Innovative, a new Breakthrough Institute report, makes the case for an entirely new model of nuclear innovation based on lessons drawn from some of the most innovative industries in today’s economy. This case study, the third in the series, assesses the “biotech-pharma networked model” of innovation in relation to the nuclear industry’s players, regulators, and public institutions. The nuclear industry will need more support in taking new technologies from the university lab to start-up companies, the authors find, and more explicit recognition of the public health benefits of nuclear compared with other energy sources.